26 pending office actions
| App # | Title | Examiner | Art Unit | Status | Filed |
|---|---|---|---|---|---|
| 18512636 | COMPOSITIONS AND METHODS FOR TREATMENT OF MITOCHONDRIAL RESPIRATORY CHAIN DYSFUNCTION AND OTHER MITOCHONDRIAL DISORDERS | SHIAO, YIH-HORNG | 1691 | Final Rejection | Nov 17, 2023 |
| 18497338 | METHODS OF DIAGNOSING AND TREATING ANXIETY DISORDER | SOLOLA, TAOFIQ A | 1625 | Final Rejection | Oct 30, 2023 |
| 18553893 | ANTIMICROBIAL ELUTING AIRWAY DEVICES | CRAIGO, WILLIAM A | 1615 | Non-Final OA | Oct 04, 2023 |
| 18033627 | COMPOSITIONS AND METHODS FOR IN VIVO GENE TRANSFER | SHIN, DANA H | 1635 | Non-Final OA | Apr 25, 2023 |
| 18181226 | NEEDLE-FREE INJECTOR, ASSOCIATED RELOADABLE AND DISPOSABLE NOZZLES, AND METHODS OF INJECTION | RODRIGUEZ, CRIS LOIREN | 3783 | Non-Final OA | Mar 09, 2023 |
| 18176546 | Compositions and Methods for Modulating Factor IX Function | TSAY, MARSHA M | 1656 | Final Rejection | Mar 01, 2023 |
| 18162061 | Retrieval Devices | MANNAN, MIKAIL A | 3774 | Non-Final OA | Jan 31, 2023 |
| 18007407 | NOVEL THERAPEUTIC USES OF COMPOUNDS FOR ENHANCING MITOCHONDRIAL FUNCTION AND TREATING MITOCHONDRIAL DISEASES | CHO, DAVID H | 1693 | Final Rejection | Jan 30, 2023 |
| 17970503 | PHYSIOLOGICAL SALINE SOLUTION AND METHODS FOR MAKING AND USING SAME | MITCHELL, EDWIN COLEMAN | 1619 | Final Rejection | Oct 20, 2022 |
| 18047189 | COMPOSITIONS AND METHODS FOR ENHANCING WEIGHT LOSS | SHIN, DANA H | 1635 | Non-Final OA | Oct 17, 2022 |
| 17938857 | Compositions and Methods for Treating Huntington's Disease and Related Disorders | GOMEZ RODRIGUEZ, JULIO WASHINGTON | 1637 | Final Rejection | Oct 07, 2022 |
| 17916998 | DECELLULARIZED MENISCAL CARTILAGE AND USES THEROF | MITCHELL, EDWIN COLEMAN | 1619 | Final Rejection | Oct 04, 2022 |
| 17931184 | System And Method Configured To Provide Extracorporeal Support For Premature Fetus | MATTHEWS, CHRISTINE HOPKINS | 3791 | Non-Final OA | Sep 12, 2022 |
| 17787433 | NOVEL DRUGGABLE TARGETS FOR THE TREATMENT OF INFLAMMATORY DISEASES SUCH AS SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) AND METHODS FOR DIAGNOSIS AND TREATMENT USING THE SAME | KAPUSHOC, STEPHEN THOMAS | 1683 | Non-Final OA | Jun 20, 2022 |
| 17777245 | COMPOSITIONS AND METHODS FOR MODULATING FACTOR VIII FUNCTION | MCKNIGHT, CIARA A | 1656 | Final Rejection | May 16, 2022 |
| 17641665 | COMPOSITIONS AND METHODS FOR TREATMENT OF DISORDERS ASSOCIATED WITH CLEC16A DYSFUNCTION OR LOSS | YOUNGBLOOD, WILLIAM JUSTIN | 1629 | Final Rejection | Mar 09, 2022 |
| 17596622 | USE OF SRRD IN THE INHIBITION OF PROTEIN AGGREGATION | WANG, CHANG YU | 1675 | Final Rejection | Dec 14, 2021 |
| 17594651 | CRISPR/CAS9 GENE EDITING OF ATXN2 FOR THE TREATMENT OF SPINOCEREBELLAR ATAXIA TYPE 2 | BABIC, CHRISTOPHER M | 1633 | Non-Final OA | Oct 25, 2021 |
| 17296722 | COMPOSITIONS AND METHODS FOR TREATING CANCER | MARVICH, MARIA | 1634 | Non-Final OA | May 25, 2021 |
| 17289877 | T CELLS FROM LYMPHATIC FLUID FOR DIAGNOSTIC AND THERAPEUTIC USE | REDDIG, PETER J | 1646 | Non-Final OA | Apr 29, 2021 |
| 17242665 | Cannula Insertion System And Methods Of Using The Same | DANG, ANH TIEU | 3771 | Non-Final OA | Apr 28, 2021 |
| 17279542 | 2' FANA MODIFIED FOXP3 ANTISENSE OLIGONUCLEOTIDES AND METHODS OF USE THEREOF | SULLIVAN, STEPHANIE LAUREN | 1635 | Final Rejection | Mar 24, 2021 |
| 17272005 | SCALABLE TAGGING OF ENDOGENOUS GENES BY HOMOLOGY-INDEPENDENT INTRON TARGETING | REGA, KYLE THOMAS | 1636 | Non-Final OA | Feb 26, 2021 |
| 17265302 | ALTERNATIVE SPLICING REGULATION OF GENE EXPRESSION AND THERAPEUTIC METHODS | MCLEOD, AFRICA MHAIRIE | 1635 | Final Rejection | Feb 02, 2021 |
| 17055075 | CRISPR INTERFERENCE BASED HTT ALLELIC SUPPRESSION AND TREATMENT OF HUNTINGTON DISEASE | NICOL, ALEXANDER W | 1634 | Final Rejection | Nov 12, 2020 |
| 16344298 | GENE TRANSFER COMPOSITIONS, METHODS AND USES FOR TREATING NEURODEGENERATIVE DISEASES | FONTAINHAS, AURORA M | 1675 | Final Rejection | Apr 23, 2019 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial